Vanberra Signal
Free trial

PlenaryAI

Curated by Signal

AI-based molecular imaging tool for clinical assessment

Health Technologyplenaryai.com

Overview

AI-based molecular imaging tool for clinical assessment. The company has developed a real-time, AI-assisted quantitative assessment tool for molecular images that can identify, segment, and classify tissue types. The company's tool is used for cancer classification on positron emission tomography (PET), and machine learning for Parkinson's disease subtype selection.

Key facts

Founded
2021
Headquarters
Gaithersburg, United States
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Homo Sentient

    Platform offering solutions for human experiences through art and AI technology

    Health TechnologyAnaheim, United States

  • My Season Birth

    Provider of software solutions for tracking & monitoring pregnancy

    Health TechnologyZephyrhills, United States

  • PriMe

    Provider of app for managing stress & anxiety

    Health TechnologyUnited States

About PlenaryAI

What does PlenaryAI do?

AI-based molecular imaging tool for clinical assessment.

Where is PlenaryAI headquartered?

PlenaryAI is headquartered in Gaithersburg, United States.

When was PlenaryAI founded?

PlenaryAI was founded in 2021.

Which sector is PlenaryAI in?

PlenaryAI operates in Health Technology.

Who are PlenaryAI's competitors?

Companies similar to PlenaryAI include Homo Sentient, My Season Birth, and PriMe.